home/news/GLAND

// news

GLAND PHARMA LIMITEDGLAND

Healthcare

← back to GLAND overview

// 01headlines2 items

01
Record Q4FY26 Results with 22% Revenue Growth and 97% Profit Increase
NSE·40d·15-May-2026, 04:32 pm
↗
02
Tentative USFDA Approval for Brimonidine Tartrate Ophthalmic Solution
NSE·113d·04-Mar-2026, 11:04 am
↗

// other symbols232 total

360 ONE WAM LIMITED ABB INDIA LIMITED ADANI ENERGY SOLUTION LTD ADANI ENTERPRISES LIMITED ADANI GREEN ENERGY LTD ADANI PORT & SEZ LTD ADANI POWER LTD ADITYA BIRLA CAPITAL LTD.ALKEM LABORATORIES LTD.AMBER ENTERPRISES (I) LTD AMBUJA CEMENTS LTD ANGEL ONE LIMITED APL APOLLO TUBES LTD APOLLO HOSPITALS ENTER. L ASHOK LEYLAND LTD ASIAN PAINTS LIMITED ASTRAL LIMITED AU SMALL FINANCE BANK LTD AUROBINDO PHARMA LTD AVENUE SUPERMARTS LIMITED

Professional analysis & precision execution. Built in India, for traders who measure edge in milliseconds.

Market Data

Symbols
News
Stock Events
NSE Holidays
BSE Holidays

Legal

Policies & Procedures

Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.

© 2026 Besseggen InfoTech LLP